Persistency Study After aP / Tdap Booster Vaccines in Adult Subjects (V113_01 Extension 1)

NCT02382913 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

315

Enrollment

INDUSTRY

Sponsor class

Conditions

Pertussis

Interventions

BIOLOGICAL: aP booster
BIOLOGICAL: TdaP booster
BIOLOGICAL: Licensed TdaP booster (Boostrix®)

Sponsor

Novartis